A detailed history of Pacifica Partners Inc. transactions in Amgen Inc stock. As of the latest transaction made, Pacifica Partners Inc. holds 1,088 shares of AMGN stock, worth $287,765. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,088
Previous 1,112 2.16%
Holding current value
$287,765
Previous $347,000 0.86%
% of portfolio
0.15%
Previous 0.15%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$309.38 - $337.38 $7,425 - $8,097
-24 Reduced 2.16%
1,088 $350,000
Q1 2024

Apr 12, 2024

SELL
$268.87 - $324.56 $2,957 - $3,570
-11 Reduced 0.98%
1,112 $316,000
Q4 2023

Jan 05, 2024

BUY
$255.7 - $288.46 $46,026 - $51,922
180 Added 19.09%
1,123 $323,000
Q3 2023

Oct 10, 2023

BUY
$218.65 - $271.46 $65,595 - $81,438
300 Added 46.66%
943 $253,000
Q2 2023

Jul 14, 2023

SELL
$214.27 - $253.37 $642 - $760
-3 Reduced 0.46%
643 $142,000
Q1 2023

Apr 11, 2023

SELL
$225.79 - $275.2 $3,386 - $4,128
-15 Reduced 2.27%
646 $156,000
Q4 2022

Jan 11, 2023

BUY
$229.03 - $291.01 $4,122 - $5,238
18 Added 2.8%
661 $174,000
Q3 2022

Oct 14, 2022

BUY
$224.46 - $253.15 $11,223 - $12,657
50 Added 8.43%
643 $150,000
Q2 2022

Jul 22, 2022

SELL
$230.71 - $256.74 $1,845 - $2,053
-8 Reduced 1.33%
593 $147,000
Q1 2022

Apr 12, 2022

BUY
$219.27 - $242.57 $8,770 - $9,702
40 Added 7.13%
601 $137,000
Q4 2021

Jan 13, 2022

SELL
$198.88 - $227.6 $2,983 - $3,414
-15 Reduced 2.6%
561 $117,000
Q2 2021

Jul 14, 2021

BUY
$233.58 - $259.14 $4,438 - $4,923
19 Added 3.41%
576 $141,000
Q1 2021

Apr 08, 2021

BUY
$221.91 - $258.6 $7,323 - $8,533
33 Added 6.3%
557 $140,000
Q4 2020

Jan 13, 2021

SELL
$216.38 - $257.67 $16,228 - $19,325
-75 Reduced 12.52%
524 $117,000
Q2 2020

Jul 15, 2020

SELL
$197.81 - $242.74 $2,571 - $3,155
-13 Reduced 2.12%
599 $154,000
Q4 2019

Feb 04, 2020

BUY
$189.21 - $243.2 $115,796 - $148,838
612 New
612 $148,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pacifica Partners Inc. Portfolio

Follow Pacifica Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacifica Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacifica Partners Inc. with notifications on news.